Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Report: Walgreens Boots Alliance to be Split Three Ways Following Buyout

Private equity firm Sycamore Partners will split the company into three units separating its US and UK retail pharmacies and its healthcare business if a privatisation bid is successful, the Financial Times reports.
Walgreens Boots Alliance Inc. has begun a strategic review of its Boots drugstore business, chief executive officer Rosalind Brewer said.
Walgreens' executive chairman Stefano Pessina is expected to maintain a significant share of the company. (Shutterstock)

Sycamore Partners is planning a three-way split of Walgreens Boots Alliance if a deal to take the struggling pharmacy chain private is reached, the Financial Times reported on Thursday, citing people familiar with the matter.

Walgreens' three businesses - US retail pharmacy, Boots UK and US healthcare - will be separated and have distinct capital structures, according to the report. Sycamore and Walgreens both declined to comment on the report.

Shares of the Deerfield, Illinois-based company rose 5 percent to $11.62 in early trading.

The report “marks another twist in the potential go-private story” for Walgreens, Leerink analyst Michael Cherny said.

ADVERTISEMENT

Walgreens has reportedly been in talks to sell itself to private equity firm Sycamore since December, but a deal is yet to be reached.

Media reports have also pointed to issues with financing for a buyout and discussion with Sycamore briefly falling out.

The financing of the take-private deal is not expected to be an obstacle, according to the FT report.

Walgreens' executive chairman Stefano Pessina, who currently holds a 17 percent stake, is expected to maintain a significant share of the company, it added.

By Bhanvi Satija and Sriparna Roy; Editing by Tasim Zahid and Shailesh Kuber

Learn more:

Why Drugstores Still Aren’t Beauty Hubs

American pharmacies once aimed to transform their stores into beauty destinations, but after years of unmet promises and underwhelming results, beauty brands are reconsidering their reliance on the drugstore and are exploring different avenues for growth.

In This Article

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.
view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

Can Big Luxury Find Its New Look?

Sex sells — if anyone can figure out what sexy means in 2026. Robert Williams tracks the search for a new silhouette at Kering’s Gucci, LVMH’s Dior and more.


VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON